|
Model Number 8637-20 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Granuloma (1876); Muscle Weakness (1967); Pain (1994); Tingling (2171); Urinary Frequency (2275)
|
Event Date 06/01/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: other relevant device(s) are: product id 8780, serial# (b)(4), implanted: (b)(6) 2013, product type catheter, ubd: 07-nov-2015, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a manufacturing representative (rep) regarding a patient receiving an unknown medication via an implantable pump.It was reported the patient was currently in surgery for the removal of an inflammatory mass (as of (b)(6) 2020).The plan was to remove the mass but leave the tip of the catheter in the csf (cerebrospinal fluid) and have the drug dispensed from the open end of the catheter (that was cut).Open-tip catheter considerations were reviewed.The rep stated they were being called to the facility later that day to assist with reducing the dose.The rep did not have any neurological symptoms related to the im (inflammatory mass) at the time of the call.No further information was available at the time of this report.
|
|
Event Description
|
Additional information was received from a healthcare provider (hcp) via a company representative (rep) indicated the symptoms were somewhat to fully resolved.No further complications were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Concomitant medical products: product id 8780, lot# , serial# (b)(6), implanted: (b)(6) 2013, explanted: , product type: catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received via a company representative.The physician who initially reported the event to them was clarified.The patient experienced progressive left leg weakness a few months ago (not otherwise specified), multiple pain problems (back and lower extremity pain), felt prickly sensation along left leg, and had increased urinary frequency (no incontinence).Regarding when the inflammatory mass was first observed, it was noted that magnetic resonance imaging was performed on (b)(6) 2020 in which the mass was observed.The mass and catheter tip removal surgery proceeded as planned on the date of the report ((b)(6) 2020).The patient was now scheduled for catheter and pump replacement on (b)(6) 2020.The information provided was noted as having been confirmed with the physician/account.
|
|
Search Alerts/Recalls
|
|
|